Zhou et al. demonstrated an involvement of GSCs in the modification of the immunosuppressive microenvironment by secreting periostin (POSTN) to recruit M2-type TAMs and promote GBM progression and tumor recurrence [45]. This evidence concerns the gene POSTN and glioblastoma.